Related Experiment Video
Updated: May 23, 2026
06:32
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Variance in Bacillus anthracis virulence assessed through Bayesian hierarchical dose-response modelling
J Mitchell-Blackwood1, P L Gurian, R Lee
1Department of Civil, Architectural and Environmental Engineering, Drexel University, Philadelphia, PA, USA. mitchell-blackwood.jade@epa.gov
Journal of Applied Microbiology
|April 21, 2012
Summary
A predictive model for Bacillus anthracis (B. anthracis) survival was developed using a Bayesian hierarchical approach. This analysis of over 11,000 data points reveals significant variability in virulence, informing risk management strategies.
Area of Science:
- Infectious disease modeling
- Risk assessment
- Microbiology
Background:
- Bacillus anthracis (B. anthracis) poses a significant biothreat.
- Understanding dose-response relationships is crucial for effective risk management.
- Limited data exists for B. anthracis dose-response due to its infectious nature.
Purpose of the Study:
- To develop a predictive dose-response model for B. anthracis survival.
- To support risk management decisions for deliberate release scenarios.
- To quantify the variability in B. anthracis virulence.
Main Methods:
- Bayesian hierarchical approach (BHA) for predictive modeling.
- Analysis of a large dataset (>11,000 data points) of guinea pig inhalation exposures.
- Utilized 76 different B. anthracis product preparations.
Main Results:
- Generated dose-response curves from extensive dose-mortality data.
- Demonstrated the utility of BHA for scenario planning (best-case to worst-case).
- Observed a wide range of virulence across different B. anthracis products.
Conclusions:
- Median virulence estimates align with previous studies.
- Upper bound virulence estimates significantly exceed prior estimates.
- Results highlight variability from product preparation and dissemination, crucial for health-based risk management.
Related Concept Videos
01:28Regulation of Bacterial Virulence
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
01:03Dose-Response Relationship: Overview
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:21Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...